Himalaya Nutravedics India share price
BSE: 544943Pharmaceuticals & Biotechnology
HIMALAYA NUTRAVEDICS INDIA LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2026
Last close ₹115.00down ₹3.95 (3.32%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹118.95.
28 Oct: open ₹118.95, high ₹118.95, low ₹115.00
Range of traded prices from listing on 29 Sep 2026 to 28 Oct 2026
₹111.00Low, 1 Oct 2026₹167.20High, 15 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹101 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. It is worked out from the results a company files with the exchange, and its first are due within weeks of listing. Price to earnings, trailing: how it is worked out
- First results duelisted 29 Sep 2026
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. It is worked out from the results a company files with the exchange, and its first are due within weeks of listing. Price to book: how it is worked out
- First results duelisted 29 Sep 2026
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Sep 2026
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 7,200
Himalaya Nutravedics India competitors and peers
Pharmaceuticals, 215 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Himalaya Nutravedics India in market cap. 1 company in the table last traded before then: its row is priced on its last trade.Healthcare companies
Himalaya Nutravedics India is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Sotac PharmaceuticalsSOTAC | 112 | 19.41 | 1.90 | +0.1% | −28.2% | 10.3% | – | 0.20% |
 Makers LaboratoriesMAKERSL | 112 | 32.65 | 1.53 | +17.6% | −61.6% | 4.8% | 11.1% | 0.00% |
 Alpa LaboratoriesALPA | 110 | – | 0.59 | +0.5% | – | – | −1.8% | 0.00% |
 Tyche IndustriesTYCHE | 105 | 23.46 | 0.74 | −21.0% | −63.5% | 3.2% | −2.5% | 3.43% |
 Veerhealth CareVEERHEALTH | 98 | 63.88 | 4.26 | +177.2% | +199.7% | 6.8% | 11.0% | 0.00% |
 Pharmaids PharmaceuticalsPHARMAID | 97 | – | 2.04 | +18.5% | – | −8.5% | −15.8% | 0.00% |
 Parmax PharmaPARMAX | 93 | – | – | −17.6% | – | – | −70.0% | 0.00% |
 Vaishali PharmaVAISHALI | 92 | 20.78 | 1.33 | – | – | 6.6% | 4.2% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Himalaya Nutravedics India announcements
Oct 2026
16 Oct · Legal
Exchange has sought clarification from Himalaya Nutravedics India Ltd on October 16, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....4 Oct · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Commercial Suit Filed Against The Company
Sep 2026
29 Sep · Listing of Equity Shares of Himalaya Nutravedics India Ltd
Trading Members of the Exchange are hereby informed that effective from September 29, 2026, the Equity Shares of Himalaya Nutravedics India Ltd (Scrip Code: 544943) are listed and admitted ....
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 27 Oct 2026 | 124.00 | 124.00 | 117.00 | 118.95 | 120.75 | 9,600 |
| 26 Oct 2026 | 133.00 | 133.00 | 122.55 | 124.05 | 126.24 | 32,400 |
| 23 Oct 2026 | 138.05 | 138.05 | 133.00 | 137.20 | 137.32 | 12,000 |
| 22 Oct 2026 | 118.00 | 144.95 | 118.00 | 137.20 | 134.66 | 20,400 |
| 21 Oct 2026 | 134.00 | 134.00 | 122.00 | 123.55 | 125.86 | 32,400 |
| 19 Oct 2026 | 147.00 | 147.00 | 132.05 | 134.35 | 137.92 | 54,000 |
| 16 Oct 2026 | 157.00 | 162.95 | 142.05 | 149.60 | 151.22 | 98,400 |
| 15 Oct 2026 | 148.50 | 167.20 | 148.50 | 156.30 | 159.45 | 86,400 |
| 14 Oct 2026 | 125.00 | 143.90 | 123.75 | 143.85 | 137.57 | 3,38,400 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 544943
- ISIN
- INE1OTR01013
- Industry
- Pharmaceuticals & Biotechnology
- CIN
- U24110TG2022PLC163732
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2022
- Share registrar
- KFin Technologies Ltd
- Keeps the register of shareholders and handles transfers and dividend payments
In BSE SME IPO